A shortage of Concerta, a leading medication for attention-deficit/hyperactivity disorder (ADHD), has forced doctors to temporarily halt new prescriptions in Japan, leaving patients without necessary treatment. The shortage is attributed to a supply-demand imbalance, with the main ingredient of Concerta classified as a Schedule I psychotropic substance.
The shortage is mostly caused by a supply-demand imbalance, as the demand for Concerta has increased due to growing awareness of adult ADHD among the public and medical professionals. Additionally, the production of another ADHD medication was temporarily halted due to potentially carcinogenic impurities, leading many patients to switch to Concerta.
The shortage has affected thousands of ADHD patients in Japan, who are now facing difficulties in obtaining their medication. Some patients have reported experiencing basic errors and difficulties in daily life due to the lack of treatment.
The shortage of Concerta is a wake-up call for us to rethink our approach to treating ADHD. We need to focus on developing skills and providing support, rather than relying solely on medication.
"The Japanese government is working to increase the supply of Concerta, but the process is challenging due to the drug’s global production plans. The government is asking the manufacturer to increase Japan’s share of Concerta within the global supply.
Shortage Cause: Supply-demand imbalance
Patient Impact: Thousands affected, difficulties in daily life
Government Response: Working to increase supply
The situation is already affecting many individuals, and time is of the essence. The government and the pharmaceutical company must respond swiftly to resolve this issue. In the meantime, patients are advised to consult their healthcare providers for interim treatment plans.
The situation highlights the need for a more balanced approach to treating ADHD, with a focus on developing skills rather than relying on medication. The Learning Success All Access Program offers a free trial and a personalized Action Plan to help individuals with ADHD.
